E-LIB Suche - Ergebnisse für: Manos, Kate

1

Poor outcomes for trial‐ineligible patients receiving polat..:

Shaw, Briony ; Chung, Eliza ; Wellard, Cameron...
eJHaem. 5 (2024) 2 - p. 325-332 , 2024

Link: https://doi.org/10.1002/..

2

Marginal zone lymphomas: a consensus practice statement fro..:

Lasica, Masa ; Anderson, Mary A. ; Boussioutas, Alex...
Internal Medicine Journal. 54 (2024) 6 - p. 1017-1030 , 2024

Link: https://doi.org/10.1111/..

3

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFI..:

Shaw, Briony ; Chung, Eliza ; Wellard, Cameron...
HemaSphere. 7 (2023) S3 - p. e24670ab , 2023

Link: https://doi.org/10.1097/..

4

Bendamustine plus rituximab for the treatment of Waldenströ..:

Arulogun, Suzanne O. ; Brian, Duncan ; Goradia, Harshita...
American Journal of Hematology. 98 (2023) 5 - p. 750-759 , 2023

Link: https://doi.org/10.1002/..

5

Immune priming with avelumab and rituximab prior to R-CHOP ..:

Manos, Kate ; Chong, Geoffrey ; Keane, Colm...
Leukemia. 37 (2023) 5 - p. 1092-1102 , 2023

Link: https://doi.org/10.1038/..

6

Myeloid somatic mutation panel testing in myeloproliferativ..:

Ross, David M. ; Thomson, Candice ; Hamad, Nada...
Pathology. 53 (2021) 3 - p. 339-348 , 2021

Link: https://doi.org/10.1016/..

7

Outcomes of non‐myeloablative allogeneic stem cell transpla..:

Nguyen, Phillip C. ; Manos, Kate ; Fong, Chun Y....
Internal Medicine Journal. 51 (2021) 11 - p. 1954-1958 , 2021

Link: https://doi.org/10.1111/..

8

Systemic ALCL Treated in Routine Clinical Practice: Outcome..:

Martinez-Calle, Nicolas ; Kirkwood, Amy A. ; Lamb, Maxine...
Advances in Therapy. 38 (2021) 7 - p. 3789-3802 , 2021

Link: https://doi.org/10.1007/..

9

Evolution of eligibility criteria for diffuse large B‐cell ..:

Loh, Zoe ; Salvaris, Ross ; Chong, Geoffrey...
British Journal of Haematology. 193 (2021) 4 - p. 741-749 , 2021

Link: https://doi.org/10.1111/..

10

Ibrutinib for central nervous system lymphoma: the Australa..:

Lewis, Katharine L. ; Chin, Collin K. ; Manos, Kate...
British Journal of Haematology. 192 (2020) 6 - p. 1049-1053 , 2020

Link: https://doi.org/10.1111/..

11

A multicenter retrospective comparison of induction chemoim..:

Ng, Zi Yun ; Bishton, Mark ; Ritchie, David...
Hematological Oncology. 37 (2019) 3 - p. 253-260 , 2019

Link: https://doi.org/10.1002/..

12

P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFI..:

Shaw, Briony ; Chung, Eliza ; Wellard, Cameron...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430917/. , 2023

Link: http://www.ncbi.nlm.nih...

13

The Influence of Immunodeficiency, Disease Features and Pat..:

Di Ciaccio, Pietro R ; Polizzotto, Mark N ; Cwynarski, Kate...
https://eprints.whiterose.ac.uk/206510/1/1-s2.0-S0006497123025491-main.docx. , 2023

Link: https://eprints.whiteros..

14

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: ..:

Wilson, Matthew R ; Eyre, Toby A ; Kirkwood, Amy A...
https://nottingham-repository.worktribe.com/output/17078441. , 2022

Link: https://doi.org/10.1182/..

15

Systemic ALCL Treated in Routine Clinical Practice:Outcomes..:

Martinez-Calle, Nicolas ; Kirkwood, Amy A ; Lamb, Maxine...
Martinez-Calle , N , Kirkwood , A A , Lamb , M , Smith , A , Khwaja , J , Manos , K , Shrubsole , C , Gray , N , Lewis , K , Tivey , A , Bishton , M J , Hawkes , E , Ahearne , M J , Osborne , W , Collins , G P , Illidge , T , Linton , K M , Cwynarski , K , Burton , C & Fox , C P 2021 , ' Systemic ALCL Treated in Routine Clinical Practice : Outcomes Following First-Line Chemotherapy from a Multicentre Cohort ' , Advances in Therapy , vol. 38 , no. 7 , pp. 3789-3802 . https://doi.org/10.1007/s12325-021-01764-0. , 2021

Link: https://research.manches..